Crinetics Pharmaceuticals (NasdaqGS:CRNX) Update / Briefing Transcript

Crinetics Pharmaceuticals (NasdaqGS:CRNX) Update / Briefing January 05, 2026 08:30 AM ET Company ParticipantsCatherine Novack - Director of Healthcare Equity ResearchToby Schilke - CFOAlex Thompson - Managing DirectorGayathri Diwakar - Head of Investor RelationsJon Wolleben - Managing DirectorJoe Schwartz - Senior Managing Director of Rare DiseasesIsabel Kalofonos - CCOGavin Clark-Gartner - Managing Director of Biotechnology Equity ResearchGarnet Howells - VP of Global Product LeaderAlan Krasner - Chief End ...